Megan Kuzmich
Nurse Practitioner · Stanford, CANPI 1427286004
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,401 of the $1,611 with a category attached, or 87.0%. It is spread thinly across 31 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations.
Across 74 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$205
- AstraZeneca$138
- Seagen Inc.$121
- Pharmacyclics LLC, An Abbvie Company$100
- Astellas Pharma US Inc$93
- Novartis$77
- plus $876 from 25 others
What the payments were for
- Food & beverage$1,40187%
- Education$21013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $205 |
| AstraZeneca(2 entities) | 6 | $138 |
| Seagen Inc. | 5 | $121 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $100 |
| Astellas Pharma US Inc | 2 | $93 |
| Novartis | 4 | $77 |
| Tersera Therapeutics LLC | 4 | $76 |
| Merck | 3 | $68 |
| Johnson & Johnson | 1 | $65 |
| Eisai Inc. | 3 | $62 |
| Daiichi Sankyo Inc. | 4 | $62 |
| Pfizer | 3 | $61 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Bayer | 3 | $51 |
| Lilly USA, LLC | 2 | $41 |
| Sanofi | 2 | $38 |
| Bristol Myers Squibb | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| AbbVie | 1 | $22 |
| Myovant Sciences Inc. | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Morphosys, US Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Acrotech Biopharma Inc. | 1 | $15 |
| Array Biopharma Inc | 1 | $11 |
| Clovis Oncology, Inc. | 1 | $6 |
How this compares
$1,611 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Stanford
- Rhonda HewittStanford$917K
- Hamta ZareStanford$428K
- Theresa Mallick-SearleStanford$193K
- Martina SpeightStanford$170K
- Helen ShihStanford$104K
- Connie WolfordStanford$69K
- Michelle GapayStanford$37K
- Elaine JangStanford$32K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.